Group 1 - The company has decided to temporarily use idle funds from convertible bonds amounting to RMB 76.8 million to supplement working capital, with a usage period not exceeding twelve months [1][2] - As of the announcement date, the company has cumulatively repaid RMB 141 million of the funds raised from the "Jin Tong Convertible Bonds," leaving a remaining balance of RMB 62.7 million [2] - The company will ensure the repayment of the temporarily supplemented working capital before the due date and will fulfill its information disclosure obligations [2] Group 2 - The board of directors and all directors of the company guarantee that the announcement content does not contain any false records, misleading statements, or major omissions [1] - The company has communicated the repayment status of the raised funds to its sponsor institution and the sponsor representative in a timely manner [1]

Summary of Key Points Core Viewpoint - The company intends to temporarily use part of the idle funds raised from the issuance of convertible bonds to supplement its working capital, ensuring that this does not affect the normal progress of its investment projects [1][5][6]. Group 1: Fundraising Overview - The company issued 5,705,370 convertible bonds at a price of 100 RMB each, raising a total of 57,053.70 million RMB, with a net amount of 561,760,105.80 RMB after deducting issuance costs [1][2]. - The funds are managed in a special account with a tripartite supervision agreement signed with the sponsor and the bank [1][2]. Group 2: Investment Projects and Usage - The total planned investment for the industrial automation and railway signal cable project is 65,233.00 million RMB, with the raised funds allocated entirely to this project [2]. - The company anticipates a temporary idle situation for the raised funds due to the construction cycle of the investment projects [2]. Group 3: Previous Use of Idle Funds - The company previously approved the use of up to 15,000 million RMB of idle funds to supplement working capital, with a repayment period not exceeding 12 months [3][4]. - All temporarily used funds have been returned to the special account as of the date of this report [3][5]. Group 4: Current Fund Usage Plan - The company plans to use up to 15,000 million RMB of idle funds for business expansion and daily operations, ensuring that the funds are only used for activities related to its main business [4][6]. - The expected savings on financial costs from this temporary use of funds is estimated at 4.5 million RMB based on the current market LPR rate of 3.0% [4]. Group 5: Approval and Oversight - The board of directors and the supervisory board have approved the use of idle funds, confirming compliance with relevant regulations and ensuring the interests of all shareholders [5][6]. - The sponsor has verified that the use of idle funds does not change the intended use of the raised funds and does not affect the investment projects [6][7].

Core Viewpoint - The company plans to use up to RMB 200 million of idle funds raised from its initial public offering to temporarily supplement working capital for a period not exceeding 12 months from the board's approval date [1][3]. Summary by Sections 1. Basic Information on Raised Funds - The company has publicly issued 60 million shares at a price of RMB 12.05 per share, raising a total of RMB 723 million, which has been verified and deposited in a special account [1][2]. 2. Investment Project Situation - The net amount of raised funds after deducting issuance costs is RMB 636.1946 million, which will be allocated to projects related to the company's main business. The total planned investment for these projects is RMB 1,066.4229 million [2]. 3. Previous Use of Idle Funds - Previously, the company used up to RMB 150 million of idle funds to supplement working capital, which has been fully returned to the special account by July 2, 2025 [3]. 4. Current Plan for Using Idle Funds - The company aims to use up to RMB 200 million of idle funds to meet daily operational needs and improve fund utilization efficiency while ensuring that the investment projects proceed as planned [3][4]. 5. Financial Impact and Measures - The use of idle funds is expected to save approximately RMB 6 million in interest expenses based on a loan market rate of 3.0%. The company assures that this will not change the intended use of the raised funds or harm shareholder interests [3][5]. 6. Approval Process - The board and supervisory committee have approved the use of idle funds, ensuring compliance with relevant regulations and that the funds will only be used for operations related to the main business [4][5]. 7. Sponsor's Opinion - The sponsor has confirmed that the use of idle funds complies with regulations and does not harm shareholder interests, supporting the company's decision to temporarily supplement working capital [5].

Group 1 - The company held its second supervisory board's fifth meeting on July 10, 2025, with all three supervisors present, and the meeting was conducted in accordance with legal and regulatory requirements [1][2] - The supervisory board approved a proposal to temporarily use up to 200 million yuan of idle raised funds to supplement working capital, ensuring that the needs of investment projects and the planned use of raised funds are met [1][2] - The decision to use the idle funds is aimed at improving the efficiency of fund utilization while meeting the company's operational needs, with a repayment period not exceeding 12 months from the date of board approval [1][2] Group 2 - The proposal received unanimous approval with 3 votes in favor, 0 against, and 0 abstentions, indicating strong support from the supervisory board [2] - The company has disclosed the verification opinions related to the use of idle raised funds on the official information platform [2] - The announcement emphasizes the commitment to transparency and compliance with disclosure requirements [2]

Group 1 - The company held its fourth supervisory board meeting, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The supervisory board approved the proposal to temporarily use part of the idle raised funds to supplement working capital, which is expected to enhance fund utilization efficiency and reduce financial costs [1][2] - The decision to use idle funds does not affect the normal implementation of investment projects and is in the interest of the company and all shareholders [1]

Group 1 - The company received a resignation letter from supervisor Li Liang due to personal reasons, which will lead to the supervisory board having fewer members than the legal minimum [1] - The company plans to abolish the supervisory board, and Li Liang will continue to fulfill his duties until the abolition takes effect [1] - The company expressed gratitude for Li Liang's contributions during his tenure as a supervisor [1] Group 2 - The company approved the temporary use of up to RMB 100 million of idle raised funds to supplement working capital, with a usage period not exceeding 12 months [2] - The company has actually used RMB 100 million of idle raised funds for temporary working capital [3] - As of July 8, 2025, the company has fully repaid the RMB 100 million of idle raised funds to the special account for raised funds [4]

Core Viewpoint - The company, Shengmei Semiconductor Equipment (Shanghai) Co., Ltd., is undergoing significant governance changes, including the cancellation of the supervisory board and an increase in the number of directors, which may impact its operational structure and strategic direction [2][7]. Group 1: Stock Performance - As of June 27, 2025, Shengmei Shanghai's stock closed at 112.9 yuan, reflecting a 3.11% increase from the previous week [1]. - The stock reached a peak price of 115.5 yuan and a low of 108.45 yuan during the week [1]. - The company's current total market capitalization is 49.822 billion yuan, ranking 16th out of 161 in the semiconductor sector and 273rd out of 5,151 in the A-share market [1]. Group 2: Corporate Governance Changes - The second supervisory board's twentieth meeting approved three key resolutions: the cancellation of the supervisory board, an increase in the number of directors, and adjustments to the share repurchase price limit [2]. - The company plans to hold its third extraordinary general meeting on July 15, 2025, to discuss the cancellation of the supervisory board and the increase in the number of directors [3]. - The board intends to increase its size from 6 to 8 members, adding independent director Jiang Shoule [5]. Group 3: Financial Management - The company approved the temporary use of up to 250 million yuan of idle raised funds to supplement working capital, with a validity period of 12 months from the board's approval [6][7]. - The share repurchase price limit has been adjusted from 99.02 yuan per share to 120.00 yuan per share to ensure the smooth implementation of the repurchase plan [8].

Core Viewpoint - The company, Sely Medical, has experienced a significant increase in stock price and has made announcements regarding the use of idle funds and credit rating adjustments [1][2][3]. Group 1: Stock Performance - As of June 27, 2025, Sely Medical's stock closed at 13.91 yuan, up 14.49% from the previous week [1]. - The stock reached a peak price of 14.2 yuan and a low of 11.65 yuan during the week [1]. - The company's current total market capitalization is 2.657 billion yuan, ranking 30th in the pharmaceutical commercial sector and 4521st in the A-share market [1]. Group 2: Company Announcements - Sely Medical plans to use up to 32.5 million yuan of idle raised funds to temporarily supplement working capital, with a usage period not exceeding 12 months [2]. - As of May 31, 2025, the company had utilized 201.8791 million yuan of the 2020 convertible bond funds, achieving an overall investment progress of 37.90% [2]. - The board and supervisory committee approved the use of idle funds, stating it would enhance fund efficiency and lower financial costs without affecting the normal use of raised funds [2]. Group 3: Credit Rating Adjustment - The credit rating for Sely Medical's convertible bonds has been adjusted from "BBB-" to "BB+" with a stable outlook [3]. - The previous rating was established on February 18, 2025, and the new rating was issued following a tracking analysis by Zhongceng Pengyuan Credit Rating Co., Ltd. [3]. - The adjusted rating means that the "Sely Convertible Bonds" can no longer be used as collateral for repurchase transactions [3].

Meeting Details - The third meeting of the Supervisory Board of Zhejiang Pava New Energy Co., Ltd. was held on June 27, 2025, via communication voting, with all three supervisors present [1]. - The meeting was chaired by the Chairman of the Supervisory Board, Chen Huaiyi, and complied with relevant laws, regulations, and the company's articles of association [1]. Resolutions Passed - The Supervisory Board approved the proposal to temporarily use part of the idle raised funds to supplement working capital, which is expected to improve the efficiency of fund utilization [1][3]. - The approved amount for temporary use is up to RMB 150 million (including this amount), and the decision aligns with the regulations of the Shanghai Stock Exchange and the company's fund management system [3]. - The voting results were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [3].

Group 1 - The third supervisory board meeting of Hainan Huluwa Pharmaceutical Group Co., Ltd. was held on June 27, 2025, in accordance with relevant laws and regulations [1][2] - The meeting was attended by all three supervisors, and the chairman of the supervisory board presided over the meeting [1][2] - The supervisory board approved the proposal to temporarily use idle raised funds to supplement the company's working capital, which aligns with regulatory requirements and does not affect the normal investment plan of the raised funds [2] Group 2 - The voting results showed unanimous support with 3 votes in favor, 0 abstentions, and 0 votes against [2] - The supervisory board believes that the temporary use of idle funds will enhance the efficiency of fund utilization and is in the best interest of all shareholders [2]